Recent Advances in Pharmaceutical Potential of Brown Algal Polysaccharides and their Derivatives

Curr Pharm Des. 2019;25(11):1290-1311. doi: 10.2174/1381612825666190618143952.

Abstract

Marine plants, animals and microorganisms display steady growth in the ocean and are abundant carbohydrate resources. Specifically, natural polysaccharides obtained from brown algae have been drawing increasing attention owing to their great potential in pharmaceutical applications. This review describes the structural and biological features of brown algal polysaccharides, including alginates, fucoidans, and laminarins, and it highlights recently developed approaches used to obtain the oligo- and polysaccharides with defined structures. Functional modification of these polysaccharides promotes their advanced applications in biomedical materials for controlled release and targeted drug delivery, etc. Moreover, brown algal polysaccharides and their derivatives possess numerous biological activities with anticancer, anticoagulant, wound healing, and antiviral properties. In addition, we also discuss carbohydrate- based substrates from brown algae, which are currently in clinical and preclinical studies, as well as the marine drugs that are already on the market. The present review summarizes the recent development in carbohydratebased products from brown algae, with promising findings that could rapidly facilitate the future discovery of novel marine drugs.

Keywords: Brown algae; alginate; fucoidan; laminarin; marine drugs; oligosaccharides; polysaccharides..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alginates
  • Drug Delivery Systems
  • Glucans
  • Phaeophyceae / chemistry*
  • Pharmaceutical Preparations*
  • Polysaccharides / pharmacology*

Substances

  • Alginates
  • Glucans
  • Pharmaceutical Preparations
  • Polysaccharides
  • laminaran
  • fucoidan